Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-05T22:05:22.828Z Has data issue: false hasContentIssue false

A note on infectious disease, economic growth, and related government policy

Published online by Cambridge University Press:  16 June 2022

Chia-Hui Lu*
Affiliation:
Department of Economics, National Taipei University, Taipei, Taiwan

Abstract

Introducing susceptible-infected-recovered epidemiology dynamics with vaccines into an endogenous growth model, we investigate the impact of government infectious disease policy on macroeconomic performance. We find that any expenditure that improves health, whether to reduce the contact rate or increase the recovery rate or the vaccination rate, and regardless of whether it comes directly from the households or the government, has a positive impact on economic growth, but does not necessarily improve the welfare. The reason people’s health has improved but their welfare has fallen is because government expenditures must be covered by taxes, which will reduce their disposable income and consumption.

Type
Articles
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

This study was funded by the Ministry of Science and Technology of Taiwan (grant number MOST 110-2410-H-305-056-MY3).

References

Acemoglu, D. and Johnson, S. (2007) Disease and development: The effect of life expectancy on economic growth. Journal of Political Economy 115(6), 925985.CrossRefGoogle Scholar
Aksan, A.-M. and Chakraborty, S. (2014) Mortality versus morbidity in the demographic transition. European Economic Review 70(6), 470492.CrossRefGoogle Scholar
Ashraf, Q. H., Lester, A. and Weil, D. N. (2008) When does improving health raise GDP?, No 14449, NBER Working Papers, National Bureau of Economic Research, Inc, https://EconPapers.repec.org/RePEc:nbr:nberwo:14449. Google Scholar
Bloom, D. E., Canning, D. and Fink, G. (2014) Disease and development revisited. Journal of Political Economy 122(6), 13551366.CrossRefGoogle Scholar
Chakraborty, S., Papageorgiou, C. and Sebastián, F. P. (2010) Diseases, infection dynamics, and development. Journal of Monetary Economics 57(7), 859872.CrossRefGoogle Scholar
Gersovitz, M. and Hammer, J. S. (2004) The economical control of infectious diseases. Economic Journal 114(492), 127.CrossRefGoogle Scholar
Gersovitz, M. and Hammer, J. S. (2005) Tax/subsidy policies toward vector-borne infectious diseases. Journal of Public Economics 89(4), 647674.CrossRefGoogle Scholar
Goenka, A. and Liu, L. (2012) Infectious diseases and endogenous fluctuations. Economic Theory 50(1), 125149.CrossRefGoogle Scholar
Goenka, A. and Liu, L. (2020) Infectious diseases, human capital and economic growth. Economic Theory 70(1), 147.CrossRefGoogle Scholar
Goenka, A., Liu, L. and Nguyen, M.-H. (2014) Infectious diseases and economic growth. Journal of Mathematical Economics 50(2), 3453.CrossRefGoogle Scholar
Hethcote, H. W. (2008) The basic epidemiological models. In: Ma, S. and Xia, Y. (eds.), Mathematical Understanding of Infectious Disease Dynamics, Singapore: World Scientific.Google Scholar
Kydland, F. E. and Prescott, E. C. (1982) Time to build and aggregate fluctuations. Econometrica 50(6), 13451370.CrossRefGoogle Scholar
Kydland, F. E. and Prescott, E. C. (1991) Hours and employment variation in business cycle theory. Economic Theory 1(1), 6381.CrossRefGoogle Scholar
Lucas, R. E. (1988) On the mechanics of economic development. Journal of Monetary Economics 22(1), 342.CrossRefGoogle Scholar
Toda, A. A. (2020). Susceptible-Infected-Recovered (SIR) dynamics of COVID-19 and economic impact. arXiv: 2003.11221 [q-bio.PE].Google Scholar
Weil, D. N. (2007) Accounting for the effect of health on economic growth. Quarterly Journal of Economics 122(3), 12651306.CrossRefGoogle Scholar